Vicarious Surgical Inc. (RBOT), a next-generation robotics technology company, Thursday announced the appointment of Sarah Romano as Chief Financial Officer, with effect from April 1.
Romano will lead Vicarious Surgical's financial strategy, bringing extensive experience in capital markets. Most recently, Romano was with Entero Therapeutics as CFO.
In the pre-market trading, Vicarious is 3.38% higher at $9.49 on the New York Stock Exchange.
For comments and feedback: editorial@rttnews.com